文献速递儿童神经与发育行为

年龄与发育进程问卷在12至60月龄儿童中识别发育迟缓效用的系统综述与Meta分析

Utility of the Ages and Stages Questionnaire to Identify Developmental Delay in Children Aged 12 to 60 Months: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Pediatr · 2022-01-01

该系统综述与Meta分析共纳入43项研究(其中36项进入Meta分析),评估年龄与发育进程问卷(ASQ)在12至60月龄儿童中识别发育迟缓的筛查或诊断效用。ASQ-2SD预测任一领域任何发育迟缓的合并敏感度为0.77、特异度为0.81,预测严重迟缓的合并敏感度为0.84、特异度为0.77;运动与认知领域特异度较高但敏感度低,证据确定性为低至极低。

要点

  • 12至60月龄儿童通过ASQ所有领域时,无严重发育迟缓的可能性为中等(证据确定性低)。
  • ASQ运动或认知领域未通过时,分别存在相应领域迟缓的可能性为中等(证据确定性极低)。
  • ASQ-2SD预测任一领域任何迟缓的阳性似然比为4.10,未达到大于5的排除标准。

核心结论

  • 12至60月龄儿童通过ASQ所有领域时,无严重发育迟缓的可能性为中等(证据确定性低)。
  • ASQ运动或认知领域未通过时,分别存在相应领域迟缓的可能性为中等(证据确定性极低)。

研究设计与样本

  • 系统综述与Meta分析,检索Medline、EMBASE、CINAHL、PsycINFO和Mednar自建库至2021年12月。
  • 初检获5777条引文,43项研究纳入综述,其中36项纳入Meta分析。
  • 纳入标准为ASQ在12至60月龄进行,或ASQ中位年龄至少12个月且正式发育评估在ASQ后2个月内完成。
  • 采用Stata 16.1进行Meta分析,QUADAS-2评估偏倚风险,GRADE评估证据确定性。

主要发现

  • ASQ-2SD预测1个及以上领域任何迟缓(n=16):合并敏感度0.77(95%CI 0.64-0.86),特异度0.81(95%CI 0.75-0.86),阳性似然比4.10(95%CI 3.17-5.30),阴性似然比0.28(95%CI 0.18-0.44)。
  • ASQ-2SD预测1个及以上领域严重迟缓(n=15):合并敏感度0.84(95%CI 0.75-0.90),特异度0.77(95%CI 0.71-0.82),阳性似然比3.72(95%CI 2.98-4.64),阴性似然比0.20(95%CI 0.13-0.32)。
  • ASQ-2SD运动领域预测运动迟缓(n=7):合并敏感度0.41(95%CI 0.26-0.57),特异度0.94(95%CI 0.87-0.97),阳性似然比6.5(95%CI 3.8-11.1),阴性似然比0.63(95%CI 0.50-0.81)。
  • ASQ-2SD认知领域预测认知迟缓(n=2):合并敏感度0.44(95%CI 0.24-0.65),特异度0.93(95%CI 0.81-0.95),阳性似然比6.4(95%CI 2.4-16.8),阴性似然比0.61(95%CI 0.43-0.86)。
  • 证据确定性为低或极低。

关键数值与推荐

  • 以ASQ得分在1个以上领域低于均值超过2个标准差(ASQ-2SD)为阳性标准。
  • 以阳性似然比大于5和阴性似然比0.2或以下分别作为排除或纳入发育迟缓的参考阈值,需至少中等概率。

临床怎么用

  • ASQ所有领域通过时,可中等概率认为12至60月龄儿童无严重发育迟缓(证据确定性低)。
  • ASQ运动或认知领域未通过时,可中等概率认为分别存在运动或认知迟缓(证据确定性极低)。
  • ASQ-2SD预测任一领域任何迟缓的阳性似然比4.10未达大于5标准,阴性似然比0.28未达0.2或以下标准。
  • ASQ运动领域预测运动迟缓的阳性似然比6.5(95%CI 3.8-11.1),认知领域预测认知迟缓的阳性似然比6.4(95%CI 2.4-16.8)。

局限性

  • 证据确定性为低或极低。
  • 认知领域预测认知迟缓的Meta分析仅纳入2项研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The Ages and Stages Questionnaire (ASQ) is a commonly used developmental screening tool, but its utility is debated. OBJECTIVES: To conduct a a systematic review and meta-analysis to evaluate ASQ's utility as a screening or diagnostic tool to identify developmental delay in children aged 12-60 months. DATA SOURCES: Medline, EMBASE, CINAHL, PsycINFO, and Mednar were searched from inception until December 2021. STUDY SELECTION: Studies meeting both criteria were included. ASQ was performed at age 12 to 60 months or where the median age at ASQ was at least 12 months and formal developmental assessments were done within 2 months of ASQ. DATA EXTRACTION AND SYNTHESIS: True positive, false positive, false negative, and true negatives from individual studies were extracted. Meta-analysis was conducted with Stata version 16.1. Risk of bias was assessed using the QUADAS-2 tool. Certainty of evidence (COE) was assessed using GRADE guidelines. MAIN OUTCOMES AND MEASURES: Ability of ASQ scores more than 2 SDs below the mean in more than 1 domain (ASQ-2SD) to identify any developmental delay or severe delay. Based on generally accepted interpretation of likelihood ratio (LR) values, a positive LR (PLR) more than 5 and a negative LR (NLR) of 0.2 or less were considered necessary to rule in or rule out developmental delay, respectively, with at least moderate probability. RESULTS: Initial search yielded 5777 citations of which 43 were included in the review. Of them, 36 were included in the meta-analysis. The pooled sensitivity, specificity, PLR, and NLR are as follows: ASQ-2SD to predict any delay in 1 or more domain (n = 16), 0.77 (95% CI, 0.64-0.86), 0.81 (95% CI, 0.75-0.86), 4.10 (95% CI, 3.17-5.30), and 0.28 (95% CI, 0.18-0.44); ASQ-2SD to predict severe delay in 1 or more domain (n = 15), 0.84 (95% CI, 0.75-0.90), 0.77 (95% CI, 0.71-0.82), 3.72 (95% CI, 2.98-4.64), and 0.20 (95% CI, 0.13-0.32); ASQ-2SD motor domain to predict motor delay (n = 7), 0.41 (95% CI, 0.26-0.57), 0.94 (95% CI, 0.87-0.97), 6.5 (95% CI, 3.8-11.1), and 0.63 (95% CI, 0.50-0.81); and ASQ-2SD cognitive domain to predict cognitive delay (n = 2), 0.44 (95% CI, 0.24-0.65), 0.93 (95% CI, 0.81-0.95), 6.4 (95% CI, 2.4-16.8), and 0.61 (95% CI, 0.43-0.86). The COE was low/very low. CONCLUSIONS AND RELEVANCE: If a child aged 12 to 60 months passes all ASQ domains, there is a moderate probability that they do not have severe developmental delay (low COE). If a child aged 12-60 months fails the motor or cognitive domain of ASQ, there is a moderate probability that they have some motor or cognitive delay, respectively (very low COE). TRIAL REGISTRATION: PROSPERO (CRD42021268543).

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Muthusamy S, Wagh D, Tan J, et al. Utility of the Ages and Stages Questionnaire to Identify Developmental Delay in Children Aged 12 to 60 Months: A Systematic Review and Meta-analysis. JAMA Pediatr. 2022. PMID: 36036913. doi:10.1001/jamapediatrics.2022.3079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。